Your cart
Your cart is empty
Continue shopping
Bundle & Save
Pharmacor
Quetiapine
Sale price
$3.49
-21%
Regular price
$4.41
Regular price
$3.49
Unit price
per
Low stock
In stock, ready to ship
Product Sold Out
Loading...
More Information (API / 25mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (API / 100mg x 90 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (API / 200mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (API / 300mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Sigma / 25mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Sigma / 100mg x 90 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Sigma / 200mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Sigma / 300mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Symbion / 25mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Symbion / 100mg x 90 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Symbion / 200mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (Symbion / 300mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (CH2 / 25mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (CH2 / 100mg x 90 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (CH2 / 200mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
More Information (CH2 / 300mg x 60 Tabs)
Active Ingredients
quetiapine fumarate 28.784mg Equivalent: quetiapine 25mg
Free-From
Gluten free
Gelatin free
Indicators
Quetiapine is indicated for:
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Adults
Maintenance treatment of bipolar I disorder, as monotherapy or in combination with lithium or sodium valproate, for the prevention of relapse/recurrence of manic, depressive or mixed episodes
Treatment of depressive episodes associated with bipolar disorder (see Dosage and Administration)
Treatment of acute mania associated with bipolar I disorder as monotherapy or in combination with lithium or sodium valproate
Treatment of schizophrenia
Children/adolescents aged 10 to 17 years
Monotherapy treatment of acute mania associated with bipolar I disorder
Treatment of schizophrenia (adults/adolescents aged 13 to 17 years)
Tablet Description
Peach coloured, film coated, round shape, biconvex tablets, debossed with 262 on one side and plain on other side
Storage Conditions
Store below 25 degrees Celsius
Additional Information
Warnings
Connecting Care, Simplifying Supply.
At Pharmacor, we bridge the gap between healthcare providers and seamless supply solutions, ensuring care is always within reach.
